MedX Health Corp | March 03, 2022
MedX Health Corp.("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce a Memorandum of Understanding (“MOU”) and the launch of a new commercialization pilot project with Health Partners (OH) Limited, a well-respected, privately-owned corporate health, treatment and primary care services company in the United Kingdom. Serving a broad client base comprising corporates, government agencies, insurers, health trusts, pension funds and individuals, Health Partners (“HP”) employs 700+ people with telehealth, mobile and on-site operations across the UK and the Republic of Ireland.
The pilot will span three to six months and involve an estimated 600 patients across two of HP’s sites. Upon the successful completion of the pilot, the MedX DermSecure® Screening Platform will be made available to Health Partners' two million-plus patients. The agreement is the latest initiative in MedX’s global commercialization strategy and follows pilots recently launched across the Europe and Middle East region.
"Health Partners’ Clinical Team constantly strives to identify leading technological innovations that offer the highest level of support to our two million-plus patients. MedX's leading skin assessment technology allows dermatologists to not only make more accurate diagnoses of pigmented lesions and moles, but to do that remotely and quickly. We are very proud to be partnering with MedX Health to bring this innovative and life-changing service to our clients.”
Health Partners Managing Director Andrew Noble
In addition to expanding its DermSecure® Screening Platform network globally, MedX has focused on building a presence in multiple market verticals such as pharmacies, medical clinics, building hubs, medical scanning clinics, mobile and remote medical practices, as well as esthetics and skincare clinics. The partnership with Health Partners represents MedX’s expansion into a new vertical; occupational health and wellbeing services.
MedX Managing Director, Europe, Middle East and Africa (EMEA), Naman Demaghlatrous, added, "MedX is pleased to have established a presence in the strategic occupational health vertical. Health Partners brings our technology to a population of more than two million workers across the United Kingdom, thus expanding our footprint in the EMEA region considerably. We continue to execute on our strategy to identify strategic partnerships in the region that will allow us to grow our business and save lives simultaneously.”
Health Partners will pilot MedX’s high-definition image-capture technology, SIAscopy®, and its secure, cloud-based patient management system, DermSecure®, which transmits and stores patient data throughout the assessment process. MedX's SIAscopy® is the only technology available that captures five high-resolution images of suspicious moles, lesions and skin conditions, including four spectrophotometric images taken 2mm below the skin's surface. This technology provides detailed patient scans, which a certified dermatologist can virtually assess within 72 hours.
"We are honoured to be working with Health Partners on this most important initiative. According to Health & Safety Executive-commissioned research, there are more than 3000 cases of skin cancer annually in the construction industryalone. We are delighted to be entering the occupational health services market with a leader in the industry," stated Mike Druhan, MedX President, Dermatology Services.
About Health Partners (OH) Ltd.
Health Partners, headquartered in Uckfield, East Sussex, United Kingdom, is a leading health and wellbeing company, providing a full range of corporate health, treatment and primary care services to corporates, government, insurers, health trusts, pension funds and families. We combine expert advice and clinical services with smart systems to deliver impact-driven health programmes, tailored to improve people’s wellbeing and performance.
Health Partners is founded on patient privacy and holds a significant number of accreditations, certifications and memberships, including ISO27001, CQC, SEQOHS and ISO9001. Health Partners offers its services across the United Kingdom and the Republic of Ireland, reaching two million plus people in organisations across several industries.
About MedX Health Corp.
MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view suspicious moles and lesions up to 2mm beneath in a pain-free, non-invasive manner. Its patented software then creates real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil and Turkey.
Cognizant | March 02, 2022
Cognizant today announced it is collaboratingwith Microsoft to delivera new digital health solution to enhance remote patient monitoring for improved medical care.
Cognizant's new solution, leveraging components of the Microsoft Cloud for Healthcare, is the first of several planned offerings that combine remote patient monitoring and virtual health, utilizing products like smart watches, blood pressure monitors, and glucose meters to collect and communicate patient health data to providers. Built-in analytics allow providers to cross-reference historical health information to gain patient insights and potentially identify early warning signs of chronic conditions so preventative measures can be taken. Additionally, the solution's remote capabilities enable telehealth visits, which continue to be a valuable option to mitigate barriers of care for patients with accessibility constraints, as well as implement time-sensitive interventions and improve personalized care. With chronic diseases expected to account for 70% of global deaths by 2030, advancements in digital integration are quickly becoming recognized as an optimal approach to preventing, managing, and treating disease.*
As an early Microsoft Cloud for Healthcare partner, Cognizant has designed a solution that leverages Microsoft Azure services including FHIR, API Services, and Teams integration to improve scalability and reliability. This digital healthcare endeavor is backed by Cognizant's dedicated Microsoft Business Group, bringing together Cognizant's digital modernization expertise with Microsoft's focus on building Industry Clouds to deliver a commercially available, comprehensive, healthcare solution.
This new offering is the first in a series of digital healthcare solutions from Cognizant as the company accelerates its client offerings aimed at implementing advanced healthcare technology to increase patient engagement, enhance personalized care, provide remote patient monitoring, and facilitate improved patient outcomes. Future offerings will build upon existing solution capabilities to help clients expedite implementation.
"The bridging of technology and healthcare is creating new opportunities to improve how providers monitor the health of their patients and engage with them for time-sensitive interventions. Utilizing data analytics, secure cloud technology and interoperability products, our collaboration with Microsoft offers a unique, scalable solution that aims to connect providers and patients, and enhances the quality, timeliness, and personalization of healthcare."
Surya Gummadi, Head of Cognizant Healthcare
"Cognizant's new virtual healthcare solution utilizes differentiated capabilities, built on the secure and compliant Microsoft Cloud, that make it easy for people to collect and share health data using their own devices, while ensuring that providers have the data and insights they need to diagnose and treat patients," saidTom McGuinness, Corporate Vice President, Global Healthcare and Life Sciences, Microsoft. "We look forward to combining our technologies and collective expertise to deliver additional solutions that offer high quality healthcare and enable patient well-being."
Cognizantengineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life.
BAYADA | February 28, 2022
BAYADA Home Health Care, a leading not-for-profit home health care provider today launched its new, innovative suite of digital care transition and coordination solutions to assist hospitals and health plan point venture partners to better serve patients in their homes and communities. BAYADA has selected digital health care company, Dina, its current technology partner, as the platform to power these new, tech-enabled services.
The new digital tools leveraged by BAYADA will identify risks and track interventions as part of a new longitudinal care management program, bridging the acute and post-acute care worlds. By improving patient transitions from hospital to home-based care, BAYADA will help care teams stay connected, and create better, more cost-effective outcomes for patients and providers.
In a BAYADA trial including a cohort of patients with complex care needs, the approach has already created a significant impact. Patient hospitalization and emergency department visit rates were reduced by 42% and 30%, respectively, and the progression of patients moving from their homes into long-term, facility-based nursing care has also slowed.
“We’re excited to launch a highly scalable tech platform that offers seamless clinical integration, so we can coordinate multiple specialty services for seniors to help them stay safe and well cared for in their homes,” said David Baiada, CEO of BAYADA Home Health Care. “This will become increasingly important as care continues to move into homes, where people want to be.”
The COVID-19 pandemic has accelerated the adoption of home-based care, and most older Americans say they want to age in place.
“As organizations prepare to deliver care in a post-COVID world, it’s important that they not only invest in telehealth and remote patient monitoring capabilities, but also partner with forward-thinking homecare providers to better serve people in the home setting. We look forward to working with BAYADA to implement this new technology, and managing the care delivery logistics to make care-at-home safe, coordinated, reliable and excellent for patients and their families.”
Ashish V. Shah, CEO of Dina
The new tech-enabled services not only benefit patients, but major health systems as well, allowing BAYADA partners to:
Digitally transform post-acute care (PAC) network management and streamline the transitions of care experience for patients moving from hospital to home.
Create virtual care teams across disparate post-acute and community-based providers that connect physicians, nurses, care managers, patients, and their families with real-time, secure, mobile messaging, leading to fewer unplanned emergency room visits and readmissions.
Implement new, innovative care-at-home delivery models that keep the home as the primary destination for medically complex patients.
Address the health equity and social determinants of health (SDOH) needs for patients through data-driven partnerships with local, community-based service providers.
Better support the emerging needs of family caregivers as they work to formally collaborate with care teams to deliver exceptional outcomes at a lower cost.
BAYADA is one of the fastest-growing home health and hospice joint venture partners in the country and has joined forces with several major health systems and health plans in joint ventures and value-based care arrangements.
About BAYADA Home Health Care
BAYADA Home Health Care was founded by J. Mark Baiada in 1975 and provides nursing, rehabilitative, therapeutic, hospice and assistive care services to children, adults and seniors in the comfort of their homes. Headquartered in the Greater Philadelphia suburbs based in New Jersey, BAYADA employs more than 26,000 nurses, home health aides, therapists, medical social workers and other home health care professionals who serve their communities in 23 states from 347 locations, with locations in Canada, Germany, India, Ireland, New Zealand, South Korea and the United Kingdom.
In 2018, Baiada oversaw the company’s unprecedented transition to a not-for-profit organization to ensure BAYADA’s mission, purpose and business model would endure, and to help BAYADA realize its vision of helping millions of people worldwide experience a better quality of life at home; in early May 2019, the organization served its one millionth client.
Dina powers the future of home-based care. We are an AI-powered care-at-home platform and network that can activate and coordinate multiple home-based service providers, engage patients directly, and unlock timely home-based insights that increase healthy days at home. The platform creates a virtual experience for the entire healthcare team so they can communicate with each other--and help patients and families stay connected--even though they may not physically be under the same roof. Dina helps professional and family caregivers capture rich data from the home, using artificial intelligence to recommend evidence-based, non-medical interventions.